Education
About Us
Working with TipRanks
Follow Us
Lite Strategy Inc (LITS)
:LITS
LITS Stock Chart & Stats
$1.98
--
Market closed
$1.98
--
Day’s Range― - ―
52-Week Range$1.46 - $9.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.01M
Market Cap
$68.81M
Enterprise ValueN/A
Total Cash (Recent Filing)$26.91M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Nov 18, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 16, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding35,655,155
10 Day Avg. Volume745,080
30 Day Avg. Volume1,012,103
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)0.86
Price to Sales (P/S)0.44
P/FCF Ratio-0.56
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Lite Strategy News
LITS FAQ
What was Lite Strategy Inc’s price range in the past 12 months?
Lite Strategy Inc lowest stock price was $1.46 and its highest was $9.00 in the past 12 months.
What is Lite Strategy Inc’s market cap?
Lite Strategy Inc’s market cap is $68.81M.
When is Lite Strategy Inc’s upcoming earnings report date?
Lite Strategy Inc’s upcoming earnings report date is Nov 18, 2025 which is in 20 days.
How were Lite Strategy Inc’s earnings last quarter?
Currently, no data Available
Is Lite Strategy Inc overvalued?
According to Wall Street analysts Lite Strategy Inc’s price is currently Overvalued.
Does Lite Strategy Inc pay dividends?
Lite Strategy Inc pays a Notavailable dividend of $1.75 which represents an annual dividend yield of N/A. See more information on Lite Strategy Inc dividends here
What is Lite Strategy Inc’s EPS estimate?
Lite Strategy Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lite Strategy Inc have?
Lite Strategy Inc has 35,655,155 shares outstanding.
What happened to Lite Strategy Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lite Strategy Inc?
Currently, no hedge funds are holding shares in LITS
Lite Strategy Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.44%
12-Months-Change
Fundamentals
Return on Equity
-63.84%
Trailing 12-Months
Asset Growth
-55.81%
Trailing 12-Months
Company Description
Lite Strategy Inc
MEI Pharma, Inc. is a pharmaceutical company focused on the clinical development of oncology therapies. The company is dedicated to advancing a pipeline of drug candidates for the treatment of cancer, with a particular emphasis on hematologic malignancies. MEI Pharma's core products include investigational drugs intended to improve outcomes for patients with cancer, often through novel mechanisms of action or unique therapeutic approaches.
Technical Analysis
ABVC BioPharma
―
Jasper Therapeutics
―
Prelude Therapeutics
―
Gain Therapeutics
―
Estrella Immunopharma
―
Ownership Overview
0.26% Insiders
1.21% Mutual Funds
<0.01% Other Institutional Investors
97.02% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---